← Back to headlines
GSK Secures China Approval for Exdensur in Nasal Polyps Treatment
GSK has received regulatory approval in China for its drug Exdensur, intended for the treatment of nasal polyps. This approval marks an expansion of the company's respiratory portfolio in the region.
8 Apr, 09:12 — 8 Apr, 09:12
Sources
Showing 1 of 1 sources
